Mosaic Down syndrome is a variant of Down syndrome. Down syndrome is a congenital (present at birth) genetic condition that occurs when a person has three copies of chromosome 21 instead of two (the ...

Tovar is one of nearly 200 young scientists across the nation whose research and job prospects have been jeopardized by the sudden termination of the NIH’s MOSAIC grant program, one of many ended by ...

Launching on Thursday, the park's brand-new 100th Anniversary Digital Mosaic is a one-of-a-kind tribute to the people and memories that have shaped the park over the last century. Guests are ...

Belgium is on the board! The Saskatchewan Roughriders added a 45 th country to their All-Time list of players’ birthplaces on Tuesday when Belgian-born defensive end Sylvain Yondjouen was selected in ...

Mosaic Artist Ed Chapman has successfully created biscuit versions of Judi Dench and David Bowie as part of his new work... He joins Seán to discuss.

At Martin Luther University Halle-Wittenberg in Germany, a team of researchers recently reported developing an RNA-based antiviral agent that confers strong protection against cucumber mosaic ...

LET’S BEGIN with the window, since it’s the crux of the matter — the axis that binds the saint to the half-naked cereal eaters, the devout icon-makers to the merry glassblower. The center ...

Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex Pharmaceuticals. The agreement transforms Mosaic from a ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex Pharmaceuticals. The small ...

Grammy Award-winning guitarist Carlos Santana was rushed to a hospital in San Antonio due to dehydration before his scheduled performance on Tuesday. Santana, 77, was reportedly doing a soundcheck ...

In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s development path; the compounds will be developed as proprietary combination therapies Syncona Ltd, ...